Eliminating government waste, fraud, abuse, and mismanagement is challenging. Every program receives the taxpayer’s money and support from vested interests, and its existence is rarely tied to results. Congress is supposed to provide oversight and accountability but even when hearings are held, they do not usually lead to the consolidation or elimination of programs. In […]
President Donald Trump has made addressing healthcare costs a priority of his second term in office. While this is a noble goal, it is important that this goal is achieved while rejecting foreign price controls. On September 30, 2026, the Center for Medicare and Medicaid Innovation (CMMI) announced it had finalized the Global Benchmark for […]
The federal 340B Drug Pricing Program was created in 1992 to help federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. The lack of a clear patient definition and inadequate accountability and transparency have allowed hospitals and contract pharmacies to generate profits […]
April 20, 2026 U.S. House of Representatives Washington, D.C. 20515 Dear Representative, On behalf of the more than one million members and supporters of the Council for Citizens Against Government Waste (CCAGW), I am pleased to provide you with Citizens Against Government Waste’s public comments to the Health Resources and Services Administration regarding their request […]
April 20, 2026 U.S. Senate Washington, D.C. 20510 Dear Senator, On behalf of the more than one million members and supporters of the Council for Citizens Against Government Waste (CCAGW), I am pleased to provide you with Citizens Against Government Waste’s public comments to the Health Resources and Services Administration regarding their request for information […]
Lowering the cost of drugs is a laudable objective, especially in Florida, which has 4.2 million seniors over the age of 65 and the largest percentage of such residents of any state. Florida policymakers are discussing ways to lower the cost of medicine and Floridians of all ages should be aware of a bill that […]
The United States is the global leader in developing innovative and life-saving cures and treatments thanks to the investments made by pharmaceutical companies in the United States, including the vaccines that helped end the coronavirus pandemic. Vaccines are crucial to the physical and economic health of not just Americans but also people across the rest […]
The 340B Drug Discount Program was given the laudable goal of helping federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. However, like many other well-intended federal programs 340B has gone off the rails due to the lack of clear intent and […]
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
Federal healthcare programs are often well-intended but end up costing more than expected and become subject to waste, fraud, abuse, and mismanagement. One of the best (or worst) examples of such a result is the 340B Drug Pricing Program, which is administered by the Health Resources and Services Administration (HRSA). The lack of clear intent […]
